MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

Search

IQVIA Holdings Inc

Closed

SectorHealthcare

154.27 -7.8

Overview

Share price change

24h

Current

Min

154.26

Max

158.16

Key metrics

By Trading Economics

Income

152M

437M

Sales

58M

4B

P/E

Sector Avg

23.538

63.778

EPS

3.12

Profit margin

11.041

Employees

88,000

EBITDA

162M

1B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+56.67% upside

Dividends

By Dow Jones

Next Earnings

1 May 2025

Market Stats

By TradingEconomics

Market Cap

-5.3B

31B

Previous open

162.07

Previous close

154.27

News Sentiment

By Acuity

50%

50%

156 / 386 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

IQVIA Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

4 Apr 2025, 22:38 UTC

Hot Stocks

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

5 Apr 2025, 09:30 UTC

Earnings

Elon Musk's Mr. Fix-It Takes Center Stage During a Really Bad Week -- WSJ

5 Apr 2025, 01:00 UTC

Acquisitions, Mergers, Takeovers

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ

5 Apr 2025, 01:00 UTC

Acquisitions, Mergers, Takeovers

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ -2-

4 Apr 2025, 21:53 UTC

Market Talk

Maxeon's Supply Chain Move at Critical Time for Solar Panel Cos -- Market Talk

4 Apr 2025, 21:44 UTC

Top News
Acquisitions, Mergers, Takeovers

Trump Grants 75-Day Extension to Reach TikTok Deal -- 3rd Update

4 Apr 2025, 21:00 UTC

Top News

Americans Were Souring on Trump's Economic Plans Even Before Tariff Bloodbath -- WSJ

4 Apr 2025, 20:52 UTC

Market Talk

Peloton Likely to Escape Tariffs Unscathed -- Market Talk

4 Apr 2025, 20:52 UTC

Top News

Trump Can Cut Teacher-Training Programs For Now, Supreme Court Says -- WSJ

4 Apr 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4 Apr 2025, 20:48 UTC

Top News

The Score: Nike, Apple, Stellantis and More Stocks That Defined the Week -- WSJ

4 Apr 2025, 20:45 UTC

Top News

Hiring Defied Expectations in March, With 228,000 New Jobs -- 6th Update

4 Apr 2025, 20:32 UTC

Top News

Dow Tumbles 2,000 Points, Bonds Rally After China Retaliates Against Trump Tariffs -- WSJ

4 Apr 2025, 20:21 UTC

Top News

China Hits Back at Trump With Sweeping Tariffs on All U.S. Goods -- Update

4 Apr 2025, 20:00 UTC

Top News

Republicans March Ahead on Trump's Tax Cuts as Tariffs Kick In -- WSJ

4 Apr 2025, 19:51 UTC

Market Talk

Dollar Recovers While Recession Fears Grip Wall Street -- Market Talk

4 Apr 2025, 19:37 UTC

Top News

Trump's Team is Getting the Bond Rally It Wanted. But for the Wrong Reasons. -- WSJ

4 Apr 2025, 19:32 UTC

Market Talk

Oil Selloff Continues as China Responds to U.S. Tariffs -- Market Talk

4 Apr 2025, 19:28 UTC

Top News

U.S. Stocks Fall Further After China Retaliates Against Trump Tariffs -- Update

4 Apr 2025, 19:15 UTC

Market Talk

Costco Gold, Membership Fees Could Help Cushion from Tariff Costs -- Market Talk

4 Apr 2025, 19:12 UTC

Top News

Powell Warns of Higher Prices, Weaker Growth After Tariff Plan -- 3rd Update

4 Apr 2025, 19:11 UTC

Market Talk

U.S. Natural Gas Falls as Global Selloff Continues -- Market Talk

4 Apr 2025, 19:09 UTC

Market Talk

Mexican Stocks, Peso Tumble as Global Rout Continues -- Market Talk

4 Apr 2025, 19:09 UTC

Top News

Trump Grants 75-Day Extension to Reach TikTok Deal -- Second Update

4 Apr 2025, 19:00 UTC

Market Talk

Fed Has Limited Options to Counter Tariffs -- Market Talk

4 Apr 2025, 18:53 UTC

Market Talk

Brace for Trump's Tariff Order to Remain in Place for Extended Period -- Market Talk

4 Apr 2025, 18:51 UTC

Market Talk

Morgan Stanley Analysts Outline Paths to Recession -- Market Talk

4 Apr 2025, 18:44 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

4 Apr 2025, 18:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 Apr 2025, 18:44 UTC

Market Talk

Tariffs Won't Achieve What Trump Wants, Morgan Stanley Says -- Market Talk

Peer Comparison

Price change

IQVIA Holdings Inc Forecast

Price Target

By TipRanks

56.67% upside

12 Months Forecast

Average 242.42 USD  56.67%

High 270 USD

Low 195 USD

Based on 15 Wall Street analysts offering 12 month price targets forIQVIA Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

15 ratings

12

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

N/A / 179.12Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

156 / 386 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.